This HTML5 document contains 124 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
n11http://dx.doi.org/10.1213/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n10http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q37267027
rdf:type
wikibase:Item
schema:description
vědecký článek artículu científicu espublizáu en 2008 videnskabelig artikel wissenschaftlicher Artikel articolo scientifico наукова стаття, опублікована в жовтні 2008 vetenskaplig artikel wetenschappelijk artikel article scientifique научни чланак bilimsel makale مقالة علمية نشرت في أكتوبر 2008 scientific article published on October 2008 artigo científico article científic vedecký článok
p:P577
wds:Q37267027-29E39E13-A072-41A9-AF1F-E4D2BDD2AB33
wdt:P577
2008-10-01T00:00:00Z
p:P407
wds:Q37267027-5B11CDBC-100E-4520-A0A8-BD2502D17835
wdt:P407
wd:Q1860
p:P2860
wds:Q37267027-FCA3010C-9E8C-4703-B95B-608B39D7C2DE wds:Q37267027-E0D3AFE7-82E8-471D-87F0-CC6FAA8236EE wds:Q37267027-E175CACC-F311-4AEE-A241-9B73239CC6D2 wds:Q37267027-C891C88A-A82F-41E5-AC74-49B865E59287 wds:Q37267027-B4EA7966-8CC8-4995-B140-55A0E66E21F5 wds:Q37267027-BF1A41DD-B69C-47FB-AC05-D36B9F8A5DE9 wds:Q37267027-C783A7DD-0C21-4C6A-9090-32E862FF385D wds:Q37267027-A50578C3-AE48-4C18-83A6-B1620BD38E36 wds:Q37267027-AB1DF2EE-A35E-4748-A3F7-F58B63819219 wds:Q37267027-8DD01863-9AB8-473B-8759-3A6580317ECF wds:Q37267027-95D4A07A-A567-4DBC-8235-C06FFD2CFCEB wds:Q37267027-968E3A44-5367-4D92-9C46-457A9B226980 wds:Q37267027-9A52A472-5D54-4EC0-A778-7364CF1A0AE0 wds:Q37267027-6F53310E-AF3C-4DCA-865E-EC9099CD1F91 wds:Q37267027-711E7947-62F2-4DAF-BAC8-82663F72ACC0 wds:Q37267027-7CF1FB76-6972-4C85-9427-590048286F57 wds:Q37267027-506217F8-D5AD-4B08-8ED8-5484E57628B4 wds:Q37267027-529DEC63-CC22-4A06-A5C1-BF6DAF87B897 wds:Q37267027-5A5A448C-F8F8-470B-8890-23B0F0FCBBE8 wds:Q37267027-32019489-1147-4437-A90E-D2FEA41D646D wds:Q37267027-3F6D275A-8539-43EF-B416-4236335B45D6 wds:Q37267027-4107398A-1F43-4624-A461-90F9BDD37CD8 wds:Q37267027-411CEE87-4F05-42DE-B0F7-ED927F934711 wds:Q37267027-2C3A53D8-11E3-4713-AD3E-6CA2D7D20B1C wds:Q37267027-30FF224E-A170-46B5-A88C-04F8EB28083A wds:Q37267027-065CFD63-B41C-491F-BE61-24A5492AE928 wds:Q37267027-02084A63-708C-4674-9E90-FC7E96C35402
wdt:P2860
wd:Q39428252 wd:Q24314768 wd:Q34529515 wd:Q40226703 wd:Q44563769 wd:Q72385476 wd:Q22337395 wd:Q48597344 wd:Q35951249 wd:Q51295679 wd:Q36456961 wd:Q34544854 wd:Q34382262 wd:Q34684384 wd:Q48563303 wd:Q36740752 wd:Q34625901 wd:Q48381745 wd:Q41935892 wd:Q77458793 wd:Q42686664 wd:Q40851027 wd:Q34468461 wd:Q40903490 wd:Q43830587 wd:Q24562888 wd:Q34347655
p:P2093
wds:Q37267027-0B7D0F2B-0735-4844-937A-B429629D3784 wds:Q37267027-128F7C76-CD04-4EAF-B936-807A4B7726F8 wds:Q37267027-154DC2E1-F4E4-46CF-A0AE-28877C8BB463 wds:Q37267027-DFE8A03A-D9A5-4077-9CF2-28DA2A4C356C wds:Q37267027-E7636D0B-AF85-444E-833C-1693C738D4B7
wdt:P2093
Zhen Zhong Xu Birgitta Schmidt Chi-Fei Wang Sho-Ya Wang Peter Gerner
rdfs:label
Use of bulleyaconitine A as an adjuvant for prolonged cutaneous analgesia in the rat. Use of bulleyaconitine A as an adjuvant for prolonged cutaneous analgesia in the rat. Use of bulleyaconitine A as an adjuvant for prolonged cutaneous analgesia in the rat.
skos:prefLabel
Use of bulleyaconitine A as an adjuvant for prolonged cutaneous analgesia in the rat. Use of bulleyaconitine A as an adjuvant for prolonged cutaneous analgesia in the rat. Use of bulleyaconitine A as an adjuvant for prolonged cutaneous analgesia in the rat.
schema:name
Use of bulleyaconitine A as an adjuvant for prolonged cutaneous analgesia in the rat. Use of bulleyaconitine A as an adjuvant for prolonged cutaneous analgesia in the rat. Use of bulleyaconitine A as an adjuvant for prolonged cutaneous analgesia in the rat.
p:P50
wds:Q37267027-06F0FA61-2A4A-4CA9-A145-E7C0F5FD57CC wds:Q37267027-A071EBBC-F2C9-4D65-9904-03741397BEE3 wds:Q37267027-D34EF838-5F6A-4D43-AC4B-27E124BAF5CD
wdt:P50
wd:Q121362540 wd:Q42386007 wd:Q21256212
p:P1476
wds:Q37267027-AB9EE78B-5D56-4F5B-8DBE-8C57BEF28E50
wdt:P1476
Use of bulleyaconitine A as an adjuvant for prolonged cutaneous analgesia in the rat.
p:P304
wds:Q37267027-FC8CA238-AF89-4C84-8C98-447197336826
wdt:P304
1397-1405
p:P31
wds:Q37267027-51C3A1E0-0D2E-407D-BDC4-CD184D89E6CD
wdt:P31
wd:Q13442814
p:P698
wds:Q37267027-DD0B7F98-07CE-4EE4-A519-C626F2F091DC
wdtn:P698
n10:18806059
wdt:P698
18806059
p:P1433
wds:Q37267027-F0B4742F-A8A2-4B17-8E41-C0BDA0C9A3E0
wdt:P1433
wd:Q72225
p:P433
wds:Q37267027-CDF5A8E7-7A67-4FE4-951A-6B1456260443
p:P478
wds:Q37267027-FBE3B117-1B3C-46CF-BB25-37371B9AFBF8
wdt:P433
4
wdt:P478
107
p:P1104
wds:Q37267027-E2F8899D-09D2-4DEA-871F-244C5F434F17
wdt:P1104
9
p:P356
wds:Q37267027-DEC227F0-EAEC-4821-B47D-E9F2203AAC75
wdtn:P356
n11:ANE.0B013E318182401B
wdt:P356
10.1213/ANE.0B013E318182401B
p:P5875
wds:Q37267027-F50386C9-479C-4836-BD0A-638EF2CF080A
wdt:P5875
23269943
p:P932
wds:Q37267027-BFD90F3A-178A-4D9E-B295-D08D4EABCD5B
wdt:P932
2712758